Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02498795
Recruitment Status : Completed
First Posted : July 15, 2015
Last Update Posted : December 4, 2020
Sponsor:
Collaborator:
Universidad San Jorge
Information provided by (Responsible Party):
Maria Pilar López Royo, Universidad de Zaragoza

Tracking Information
First Submitted Date  ICMJE June 6, 2015
First Posted Date  ICMJE July 15, 2015
Last Update Posted Date December 4, 2020
Actual Study Start Date  ICMJE January 1, 2019
Actual Primary Completion Date December 31, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 3, 2017)
Change from baseline in functionality at 8 weeks as measured by Visa-p [ Time Frame: 8 weeks ]
This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.
Original Primary Outcome Measures  ICMJE
 (submitted: July 14, 2015)
Change from baseline in functionality at 8 weeks as measured by Visa-p [ Time Frame: 8 weeks ]
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: January 31, 2020)
  • Pain, as measured by Visual Analog Scale [ Time Frame: 0, 8 and 20 weeks ]
    Participants will be explained that a score of 0 indicates the absence of pain whereas a score of 10 represents the maximum tolerable pain
  • Quality of life by SF-36 [ Time Frame: 0, 8 and 20 weeks ]
    Health Survey
  • Thickness of the tendon, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]
    Tendon structure
  • Height of the jump [ Time Frame: 0, 8 and 20 weeks ]
    Jump test with a force platform
  • Concentric force of the low members [ Time Frame: 0, 8 and 20 weeks ]
    Jump test with a force platform
  • Speed of the jump [ Time Frame: 0, 8 and 20 weeks ]
    Jump test with a force platform
  • Hypervascularity, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]
    Tendon structure
  • Functionality, as measured by Visa-p [ Time Frame: 0 and 20 weeks ]
    This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.
Original Secondary Outcome Measures  ICMJE
 (submitted: July 14, 2015)
  • Pain, as measured by Visual Analog Scale [ Time Frame: 0, 8 and 20 weeks ]
  • Quality of life [ Time Frame: 0, 8 and 20 weeks ]
    Health Survey
  • Thickness of the tendon, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]
  • Height of the jump [ Time Frame: 0, 8 and 20 weeks ]
  • Concentric force of the low members [ Time Frame: 0, 8 and 20 weeks ]
  • Speed of the jump [ Time Frame: 0, 8 and 20 weeks ]
  • Hypervascularity, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]
  • Functionality, as measured by Visa-p [ Time Frame: 0 and 20 weeks ]
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
Official Title  ICMJE Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
Brief Summary The accomplishment of a treatment with Intratissue Percutaneous Electrolysis of additional form to the accomplishment of eccentric exercise's program in patients with chronic patellar tendinopathy is more effective than the accomplishment of an additional treatment with dry needling or eccentric exercise's program realized of isolated form.
Detailed Description

Experimental study randomized with double blind, whose purpose is to compare three protocols in those who apply different protocols of physical therapy to themselves in three groups of intervention with patients with chronic patellar tendinopathy.

There take part in this study young women of both sexes, of Zaragoza and of different sports clubs of entity 18 and 40 years, that they realize of habitual form (minimum 3 times a week) a sport. All of them present chronic patellar tendinopathy.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE Tendinopathy
Intervention  ICMJE
  • Other: Group of Dry Needling
    Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.
  • Other: Group of Electrolysis
    Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.
  • Other: Control Group
    Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.
Study Arms  ICMJE
  • Active Comparator: Group of Dry Needling

    They will receive a treatment of dry needling with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile.

    The needle will get in the relevant zone of treatment. The punction will be realized using the technique of entry - Hong's rapid exit. Three punction will realize in the disabled zone of 3 seconds of duration.

    Intervention: Other: Group of Dry Needling
  • Active Comparator: Group of electrolysis

    They will receive a treatment of Intratissue Percutaneous Electrolysis with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile.

    The needle will get in the relevant zone of treatment. An intensity of 3 milliampere will be in use, during 3 seconds and one will repeat 3 times.

    Intervention: Other: Group of Electrolysis
  • Placebo Comparator: Control Group
    They will receive a treatment of punction placebo with ultrasound scan together with a treatment in the one that will realize eccentric exercise's program that the patient will have to realize in his domicile.
    Intervention: Other: Control Group
Publications * López-Royo MP, Gómez-Trullén EM, Ortiz-Lucas M, Galán-Díaz RM, Bataller-Cervero AV, Al-Boloushi Z, Hamam-Alcober Y, Herrero P. Comparative study of treatment interventions for patellar tendinopathy: a protocol for a randomised controlled trial. BMJ Open. 2020 Feb 16;10(2):e034304. doi: 10.1136/bmjopen-2019-034304.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: July 14, 2015)
50
Original Estimated Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE May 2, 2020
Actual Primary Completion Date December 31, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Age understood between 18 and 40 years.
  • To practise any sport of habitual form.
  • Patients diagnosed of chronic patellar tendinopathy with a minimum of 3 months of evolution and with stable symptomatology.
  • Pain to the palpation of the tendon in the low pole of the knee and during the training or competition.
  • Punctuation of the questionnaire VISA-P under 80.

Exclusion Criteria:

  • Patient had an operation on the knee affected in the last 6 months.
  • Infiltrations in the knee affected in the last 3 months.
  • Patient who has received pharmacological treatment or physical therapy in the last 48 hours.
  • Pathology with less than 3 months of evolution.
  • To present bilateral chronic tendinopathy.
  • Punctuation of the questionnaire major or equal Visa - p of 80.
  • Inability to apply someone of the techniques of treatment or valuation for absolute or relative contraindication.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 40 Years   (Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Spain
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02498795
Other Study ID Numbers  ICMJE P115/0017
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Undecided
Responsible Party Maria Pilar López Royo, Universidad de Zaragoza
Study Sponsor  ICMJE Universidad de Zaragoza
Collaborators  ICMJE Universidad San Jorge
Investigators  ICMJE
Study Director: Eva Gómez-Trullén, PhD Universidad de Zaragoza
Study Director: Pablo Herrero, PhD Universidad San Jorge
PRS Account Universidad de Zaragoza
Verification Date December 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP